Intracranial Haemorrhage in Haemophilia Patients Is Still an Open Issue: The Final Results of the Italian EMO.REC Registry.
haemophilia A and B
incidence
intracranial haemorrhage
mortality
risk factors
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
01 Apr 2022
01 Apr 2022
Historique:
received:
25
02
2022
revised:
28
03
2022
accepted:
30
03
2022
entrez:
12
4
2022
pubmed:
13
4
2022
medline:
13
4
2022
Statut:
epublish
Résumé
Background: Intracranial hemorrhage (ICH) is a highly serious event in patients with haemophilia (PWH) which leads to disability and in some cases to death. ICH occurs among all ages but is particularly frequent in newborns. Aim: The primary aim was to assess the incidence and mortality due to ICH in an Italian population of PWH. Secondary aims were to evaluate the risk factors for ICH, the role of prophylaxis, and the clinical management of patients presenting ICH. Methods: A retrospective-prospective registry was established in the network of the Italian Association of Haemophilia Centers to collect all ICHs in PWH from 2009 to 2019 reporting clinical features, treatments, and outcomes. Results: Forty-six ICHs were collected from 13 Centers. The ICHs occurred in 15 children (10 < 2 years), and in 31 adults, 45.2% of them with mild hemophilia. Overall, 60.9% patients had severe haemophilia (15/15 children). Overall ICH incidence (×1000 person/year) was 0.360 (0.270−0.480 95% CI), higher in children <2 years, 1.995 (1.110−3.442 95% CI). Only 7/46 patients, all with severe haemophilia, had received a prophylactic regimen before the ICH, none with mild. Inhibitors were present in 10.9% of patients. In adult PWHs 17/31 suffered from hypertension; 85.7% of the mild subjects and 29.4% of the moderate/severe ones (p < 0.05). ICH was spontaneous in the 69.6% with lower rate in children (46.7%). Surgery was required in 21/46 patients for cerebral hematoma evacuation. Treatment with coagulation factor concentrates for at least three weeks was needed in 76.7% of cases. ICH was fatal in 30.4% of the cases. Of the survivors, 50.0% became permanently disabled. Only one-third of adult patients received long term prophylaxis after the acute treatment. Conclusion: The results from our Registry confirm the still high incidence of ICH in infants <2 years and in adults, particularly in mild PWHs presenting hypertension and its unfavorable outcomes. The majority of PWHs were treated on-demand before ICH occurred, suggesting the important role of prophylaxis in preventing such life-threatening bleeding.
Identifiants
pubmed: 35407576
pii: jcm11071969
doi: 10.3390/jcm11071969
pmc: PMC8999820
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Haemophilia. 2012 Jan;18(1):39-45
pubmed: 21752159
Blood Transfus. 2019 Sep;17(5):378-384
pubmed: 30747705
Haemophilia. 2020 Aug;26 Suppl 6:1-158
pubmed: 32744769
Haemophilia. 2016 Jan;22(1):32-8
pubmed: 25990680
Br J Haematol. 2011 Jan;152(2):211-6
pubmed: 21114482
Haemophilia. 2016 May;22(3):e134-8
pubmed: 26561042
Haemophilia. 2016 Jul;22(4):556-63
pubmed: 27194592
J Neurol Neurosurg Psychiatry. 2000 Nov;69(5):601-7
pubmed: 11032611
Blood. 2021 Dec 30;138(26):2853-2873
pubmed: 34411236
Br J Haematol. 2008 Feb;140(4):378-84
pubmed: 18081890
Haemophilia. 2016 Sep;22(5):e406-16
pubmed: 27650262
J Thromb Haemost. 2017 Jun;15(6):1115-1122
pubmed: 28374963
Haemophilia. 2005 Sep;11(5):452-8
pubmed: 16128887
Br J Haematol. 2017 Oct;179(2):298-307
pubmed: 28699675
Thromb Haemost. 2001 Mar;85(3):560
pubmed: 11307831
Thromb Res. 2019 Sep;181:106-111
pubmed: 31386935
Am J Hematol. 2001 Sep;68(1):37-42
pubmed: 11559935
Haemophilia. 2018 Jul;24(4):641-647
pubmed: 29635852
J Pediatr Hematol Oncol. 2019 Apr;41(3):207-209
pubmed: 30557169
Haemophilia. 2017 Mar;23(2):207-214
pubmed: 27813214
J Thromb Haemost. 2021 Mar;19(3):645-653
pubmed: 33217158